COVID-19 Vaccine: Critical Questions with Complicated Answers

The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?

(2020) Noah C Peeri et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Is COVID-19 receiving ADE from other coronaviruses?

(2020) Jason A. Tetro   MICROBES AND INFECTION

A Novel Coronavirus from Patients with Pneumonia in China, 2019

(2020) Na Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions

(2020) Yvan Jamilloux et al.   AUTOIMMUNITY REVIEWS

The Architecture of SARS-CoV-2 Transcriptome

(2020) Dongwan Kim et al.   CELL

Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients

(2020) Zhuo Zhou et al.   Cell Host & Microbe

Profile of specific antibodies to SARS-CoV-2: The first report

(2020) Ai Tang Xiao et al.   JOURNAL OF INFECTION

Detection of antibodies against SARS-CoV-2 in patients with COVID-19

(2020) Zhe Du et al.   JOURNAL OF MEDICAL VIROLOGY

Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk

(2020) Nadine Kabbani et al.   MOLECULAR PHARMACOLOGY

The proximal origin of SARS-CoV-2

(2020) Kristian G. Andersen et al.   NATURE MEDICINE

Antibody responses to SARS-CoV-2 in patients with COVID-19

(2020) Quan-Xin Long et al.   NATURE MEDICINE

Emergence of Drift Variants That May Affect COVID-19 Vaccine Development and Antibody Treatment

(2020) Takahiko Koyama et al.   Pathogens

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

(2020) Bette Korber et al.   CELL

Genetic diversity and evolution of SARS-CoV-2

(2020) Tung Phan   INFECTION GENETICS AND EVOLUTION

COVID-19 vaccine development pipeline gears up

(2020) Asher Mullard   LANCET

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

(2020) Pedro M Folegatti et al.   LANCET

Next-generation vaccine platforms for COVID-19

(2020) Debby van Riel et al.   NATURE MATERIALS

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

(2020) Quan-Xin Long et al.   NATURE MEDICINE

COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses

(2020) Muhammad Adnan Shereen et al.   Journal of Advanced Research

The immune system and COVID-19: Friend or foe?

(2020) Fereshteh Yazdanpanah et al.   LIFE SCIENCES

All eyes on a hurdle race for a SARS-CoV-2 vaccine

(2020) Christian Gaebler et al.   NATURE

Evolution of the COVID-19 vaccine development landscape

(2020) Tung Thanh Le et al.   NATURE REVIEWS DRUG DISCOVERY

Emerging Concepts and Technologies in Vaccine Development

(2020) Morgan Brisse et al.   Frontiers in Immunology

What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2

(2020) Susanne H Hodgson et al.   LANCET INFECTIOUS DISEASES

Dengue vaccine development: status and future

(2019) Annelies Wilder-Smith   Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz

Angiotensin-converting enzyme in innate and adaptive immunity

(2018) Kenneth E. Bernstein et al.   Nature Reviews Nephrology

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens

(2017) Katie Ewer et al.   Human Vaccines & Immunotherapeutics

Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody

(2017) Katherine V. Houser et al.   PLoS Pathogens

Simian adenoviruses as vaccine vectors

(2016) Susan J Morris et al.   Future Virology

Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination

(2014) Dominique Le Houézec   IMMUNOLOGIC RESEARCH

Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States

(2014) J. Duffy et al.   NEUROLOGY

Increased Incidence and Clinical Picture of Childhood Narcolepsy following the 2009 H1N1 Pandemic Vaccination Campaign in Finland

(2012) Markku Partinen et al.   PLoS One

Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells

(2010) C. Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Key concepts in immunology

(2010) Muriel Moser et al.   VACCINE

Principles of vaccine design—Lessons from nature

(2010) Fred Zepp   VACCINE

Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis

(2008) Robson A. S. Santos et al.   EXPERIMENTAL PHYSIOLOGY

Vaccine-induced enhancement of viral infections

(2008) W. Huisman et al.   VACCINE